PharVision Advisers’s Primo Brands PRMB Stock Holding History

PharVision Advisers’s Portfolio PRMB Stock Details PRMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9,422	Closed	-$279K	–	829
2025 Q2	$279K	Buy	+9,422	New	+$301K	0.4%	96

Other funds holding PRMB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PharVision Advisers's PRMB Position: Q3 2025 in Review

PharVision Advisers sold out of Primo Brands (PRMB) in Q3 2025, closing a stake of 9,422 shares — an estimated $279K sold.

PharVision Advisers first reported a position in PRMB in Q2 2025 and held it in 1 quarter. The position peaked at $279K in Q2 2025. 347 funds tracked by Wall St. Rank hold PRMB as of Q3 2025.

PharVision Advisers reported no remaining Primo Brands position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 9,422 Primo Brands shares in Q3 2025, an estimated $279K.
PharVision Advisers first reported a position in Primo Brands in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Primo Brands position peaked at $279K in Q2 2025.
347 funds tracked by Wall St. Rank held Primo Brands as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.